173 related articles for article (PubMed ID: 36999285)
1. [Not Available].
Nilsson AC; Ryding M; Poulsen CA; Blaabjerg M
Ugeskr Laeger; 2023 Mar; 185(11):. PubMed ID: 36999285
[TBL] [Abstract][Full Text] [Related]
2. Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes.
Graus F; Vogrig A; Muñiz-Castrillo S; Antoine JG; Desestret V; Dubey D; Giometto B; Irani SR; Joubert B; Leypoldt F; McKeon A; Prüss H; Psimaras D; Thomas L; Titulaer MJ; Vedeler CA; Verschuuren JJ; Dalmau J; Honnorat J
Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(4):. PubMed ID: 34006622
[TBL] [Abstract][Full Text] [Related]
3. Real-world application of the updated diagnostic criteria for paraneoplastic neurological syndromes.
Campetella L; Papi C; Sabatelli E; Marini S; Iorio R
J Neuroimmunol; 2022 Nov; 372():577972. PubMed ID: 36202000
[TBL] [Abstract][Full Text] [Related]
4. Updates in the Management of Paraneoplastic Syndrome.
Verma N; Jaffer MH; Kolli AS; Mokhtari S
Semin Neurol; 2024 Feb; 44(1):36-46. PubMed ID: 38183975
[TBL] [Abstract][Full Text] [Related]
5. Paraneoplastic neurological syndrome: growing spectrum and relevance.
Ganaraja VH; Rezk M; Dubey D
Neurol Sci; 2022 Jun; 43(6):3583-3594. PubMed ID: 35460452
[TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic Neurological Syndromes: Transitioning Between the Old and the New.
Gastaldi M; Scaranzin S; Pietro B; Lechiara A; Pesce G; Franciotta D; Lorusso L
Curr Oncol Rep; 2022 Oct; 24(10):1237-1249. PubMed ID: 35476177
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis, diagnosis and treatment of paraneoplastic neurologic syndromes.
Blaes F
Expert Rev Neurother; 2021 Jun; 21(6):675-686. PubMed ID: 33960258
[No Abstract] [Full Text] [Related]
8. Paraneoplastic neurological syndromes with onconeural antibodies: A single center retrospective study.
Oliveira V; Videira G; Samões R; Carneiro P; Neves E; Santos E
J Neurol Sci; 2020 Nov; 418():117103. PubMed ID: 32877801
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes in China.
Cai MT; Qiao S; Lai QL; Zheng Y; Yang F; Fang GL; Shen CH; Zhang YX; Ding MP
Front Immunol; 2022; 13():790400. PubMed ID: 35173717
[TBL] [Abstract][Full Text] [Related]
10. Detection of paraneoplastic antibodies and their significance in paraneoplastic neurologic syndromes: a narrative review.
Li L; Guo Y; Wang J
Ann Transl Med; 2023 Apr; 11(7):283. PubMed ID: 37090044
[TBL] [Abstract][Full Text] [Related]
11. Paraneoplastic neurological syndromes: unusual presentations of cancer. A practical review.
Braik T; Evans AT; Telfer M; McDunn S
Am J Med Sci; 2010 Oct; 340(4):301-8. PubMed ID: 20460982
[TBL] [Abstract][Full Text] [Related]
12. [Paraneoplastic neurologic syndromes. Diagnostic and pathogenetic significance of autoantibodies].
Kaiser R
Nervenarzt; 1999 Aug; 70(8):688-701. PubMed ID: 10483569
[TBL] [Abstract][Full Text] [Related]
13. [Paraneoplastic Disorders of the Central Nervous System].
Kimura A
Brain Nerve; 2021 May; 73(5):620-630. PubMed ID: 34006696
[TBL] [Abstract][Full Text] [Related]
14. New concepts in paraneoplastic neurological syndromes.
Honnorat J; Viaccoz A
Rev Neurol (Paris); 2011 Oct; 167(10):729-36. PubMed ID: 21890156
[TBL] [Abstract][Full Text] [Related]
15. [Lung cancer and paraneoplastic syndromes].
Jurado Gámez B; García de Lucas MD; Gudín Rodríguez M
An Med Interna; 2001 Aug; 18(8):440-6. PubMed ID: 11589085
[TBL] [Abstract][Full Text] [Related]
16. [Paraneoplastic neurological syndrome and autoantibodies].
Hayashi Y; Inuzuka T
Brain Nerve; 2013 Apr; 65(4):385-93. PubMed ID: 23568986
[TBL] [Abstract][Full Text] [Related]
17. Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers.
Giometto B; Grisold W; Vitaliani R; Graus F; Honnorat J; Bertolini G;
Arch Neurol; 2010 Mar; 67(3):330-5. PubMed ID: 20212230
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis and management of paraneoplastic neurological syndromes].
Saji E; Kawachi I; Nishizawa M
Brain Nerve; 2010 Apr; 62(4):319-30. PubMed ID: 20420171
[TBL] [Abstract][Full Text] [Related]
19. Caveats and Pitfalls of SOX1 Autoantibody Testing With a Commercial Line Blot Assay in Paraneoplastic Neurological Investigations.
Ruiz-García R; Martínez-Hernández E; García-Ormaechea M; Español-Rego M; Sabater L; Querol L; Illa I; Dalmau J; Graus F
Front Immunol; 2019; 10():769. PubMed ID: 31031763
[TBL] [Abstract][Full Text] [Related]
20. [Paraneoplastic neurologic syndromes: laboratory diagnostics and immunological aspects].
Hayden Z; Böröcz K; Csizmadia Z; Kellermayer Z; Balogh P; Berki T
Magy Onkol; 2019 Sep; 63(3):261-267. PubMed ID: 31533147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
